GoodRx Stock Struggles: Time to Sell?
Update: 2025-10-21
Description
GoodRx's stock is tanking! Down nearly 10% in six months while the S&P 500 soared, GoodRx faces weak customer growth, struggles against larger competitors, and a negative return on invested capital. Is it a buying opportunity or a value trap? Find out why analysts are steering clear of this struggling health tech stock.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
